- (a) Before receiving an investigational stem cell treatment, an eligible patient must sign a written informed consent.
- (b) If the patient is a minor or lacks the mental capacity to provide informed consent, a parent, guardian, or conservator may provide informed consent on the patient's behalf.
- (c) The executive commissioner by rule may adopt a form for the informed consent under this section.
Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.